Dr. Remi Creusot, PhD

 

Dr. Remi Creusot is an Assistant Professor in the Department of Medicine and principal investigator at the Columbia Center for Translational Immunology (CCTI) and the Naomi Berrie Diabetes Center. Dr. Creusot received his PhD in Immunology from the University of London at University College London (UK). He subsequently trained at Stanford University, where he was consecutively Postdoctoral Fellow, Research Associate and Instructor in the Department of Medicine, Division of Immunology and Rheumatology. He joined the CCTI in November 2012. Dr. Creusot’s research interests revolve around the pathogenesis and prevention of Type 1 diabetes (T1D), as well as the contribution of various types of antigen-presenting cells in the maintenance of peripheral tolerance. He and his group study how several biological processes involved in the maintenance of immune tolerance may be impaired in subjects with T1D, allowing the progression of the disease. Furthermore, the lab works on developing new therapeutic strategies (and improving existing ones) aimed at restoring antigen-specific tolerance and blocking autoimmunity. This research allies basic research, preclinical studies using mouse models and translational studies using patient samples and humanized mice.